✦ LIBER ✦

Cytokine polymorphisms and hepatocellular carcinoma : To B or not to B

✍ Scribed by Raymond T. Chung

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 47 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20837

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

To ‘B’ or not to ‘B’ a germinal center?

✍ Marie H. Kosco-Vilbois; Hanswalter Zentgraf; Johannes Gerdes; Jean-Yves Bonnefoy 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 745 KB

To B, or not to B: that is the question

✍ Richard B Gallagher; Dennis G Osmond 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 418 KB

To B or not to B: Pax5 in B-cell develop

To B or not to B: Pax5 in B-cell development

✍ Robert Brines 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Complete sequence and gene maps of both human and chicken major histocompatibility complex (MHC) regions have recently been reported. The MHCs of chickens and humans differ in their size, organization, complexity and evolution. The human HLA region comprises 224 genes in 3.6 mb of DNA. Of these, 12

Hepatocellular carcinoma in the very eld

Hepatocellular carcinoma in the very elderly: To treat or not to treat?

✍ Arbaje, Yamil M. ;Carbone, Paul P. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

## Abstract The authors briefly review the age distribution of HCC and the treatments used. We concluded that therapy should not be arbitrarily withheld based solely on chronological age. Older cancer patients deserve the right to be treated if they so wish. © 1994 Wiley‐Liss, Inc.

To b or not to b: The ongoing saga of pe

To b or not to b: The ongoing saga of peptide b ions

✍ Alex G. Harrison 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

## Abstract Modern soft ionization techniques readily produce protonated or multiply protonated peptides. Collision‐induced dissociation (CID) of these protonated species is often used as a method to obtain sequence information. In many cases fragmentation occurs at amide bonds. When the charge res

Immune response to cyclin B1 in hepatoce

Immune response to cyclin B1 in hepatocellular carcinoma

✍ G. Covini; E. K. Chan; M. Nishioka; S. A. Morshed; S. I. Reed; E. M. Tan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 696 KB

prolonged half-life of the protein. It was suggested that the Proteins expressed by plasmids encoding human latter feature of persistence or resistance to degradation gave cyclins and cyclin-dependent kinase 2 (CDK2) were used rise to the humoral antibody response. Another possibility as antigens in